Symphony Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,714
Closed -$1.21M 145
2019
Q4
$1.21M Buy
3,714
+168
+5% +$50.9K 0.27% 37
2019
Q3
$1.03M Sell
3,546
-4
-0.1% -$1.15K 0.22% 49
2019
Q2
$1.04M Buy
3,550
+524
+17% +$144K 0.22% 57
2019
Q1
$828K Buy
3,026
+45
+2% +$11.2K 0.21% 70
2018
Q4
$667K Buy
+2,981
New +$699K 0.2% 55
2018
Q3
Sell
-6,039
Closed -$1.25M 281
2018
Q2
$1.25M Sell
6,039
-136
-2% -$28.9K 0.25% 87
2018
Q1
$1.27M Sell
6,175
-5,926
-49% -$1.24M 0.16% 143
2017
Q4
$2.3M Sell
12,101
-9,332
-44% -$1.79M 0.23% 103
2017
Q3
$4.05M Buy
21,433
+1,733
+9% +$314K 0.45% 53
2017
Q2
$3.44M Buy
19,700
+4,759
+32% +$799K 0.39% 65
2017
Q1
$2.29M Buy
14,941
+1,656
+12% +$253K 0.22% 112
2016
Q4
$1.88M Buy
13,285
+2,869
+28% +$423K 0.19% 126
2016
Q3
$1.66M Buy
+10,416
New +$1.61M 0.17% 142
2013
Q4
Sell
-7,747
Closed -$714K 488
2013
Q3
$714K Buy
7,747
+2,334
+43% +$211K 0.07% 250
2013
Q2
$458K Buy
+5,413
New +$451K 0.04% 309

Other funds holding TMO

Symphony Asset Management's TMO Position: Q1 2020 in Review

Symphony Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 3,714 shares — an estimated $1.21M sold.

Symphony Asset Management first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $4.05M in Q3 2017. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Symphony Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
  • Symphony Asset Management sold 3,714 Thermo Fisher Scientific shares in Q1 2020, an estimated $1.21M.
  • Symphony Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
  • Symphony Asset Management's Thermo Fisher Scientific position peaked at $4.05M in Q3 2017.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.